Literature DB >> 24525029

Inflammasome activation by cystine crystals: implications for the pathogenesis of cystinosis.

Giusi Prencipe1, Ivan Caiello2, Stephanie Cherqui3, Thomas Whisenant4, Stefania Petrini5, Francesco Emma6, Fabrizio De Benedetti2.   

Abstract

Intralysosomal cystine crystal accumulation, due to mutations in the CTNS gene, is a hallmark of nephropathic cystinosis, but the role of these crystals in disease pathogenesis remains unclear. We hypothesized that, similar to other host-derived crystalline moieties, cystine crystals can induce IL-1β production through inflammasome activation. Thus, we investigated the proinflammatory effects of cystine crystals in primary human PBMCs. LPS-primed PBMCs stimulated with cystine crystals secreted IL-1β in a dose-dependent manner. Similarly to IL-1β secretion induced by other crystalline inflammasome activators, cystine crystal-induced IL-1β secretion required activation of caspase-1. Additionally, exogenous cystine crystals were internalized by monocytes, and inhibition of phagocytosis, cathepsin B leakage, generation of reactive oxygen species, and potassium efflux reduced cystine crystal-induced IL-1β secretion. Patients with cystinosis had higher levels of circulating IL-1β and IL-18 compared with controls. Analysis of inflammasome-related gene expression in PBMCs from patients with cystinosis revealed a significant increase in IL-1β and CASP-1 transcript levels compared with controls. Moreover, knockout of cystinosin in mice led to significant increases in serum IL-18 levels and kidney expression of inflammasome-related genes (Casp-1, Pycard, Il-18, Il18r1, Il1r1, and Il1rl2). Taken together, these data demonstrate that cystine crystals are endogenous inflammasome-activating stimuli, suggesting a novel role for cystine crystals in the pathogenesis of nephropathic cystinosis.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Keywords:  chronic kidney disease; genetic renal disease; immunology

Mesh:

Substances:

Year:  2014        PMID: 24525029      PMCID: PMC4033370          DOI: 10.1681/ASN.2013060653

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  27 in total

Review 1.  Cystinosis.

Authors:  William A Gahl; Jess G Thoene; Jerry A Schneider
Journal:  N Engl J Med       Date:  2002-07-11       Impact factor: 91.245

2.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

Authors:  Rafael A Irizarry; Bridget Hobbs; Francois Collin; Yasmin D Beazer-Barclay; Kristen J Antonellis; Uwe Scherf; Terence P Speed
Journal:  Biostatistics       Date:  2003-04       Impact factor: 5.899

3.  Novel reductant for determination of total plasma homocysteine.

Authors:  B M Gilfix; D W Blank; D S Rosenblatt
Journal:  Clin Chem       Date:  1997-04       Impact factor: 8.327

4.  Infantile cystinosis: a reappraisal of early and late symptoms.

Authors:  M Broyer; M Guillot; M C Gubler; R Habib
Journal:  Adv Nephrol Necker Hosp       Date:  1981

5.  IL-12p40 and IL-18 in crescentic glomerulonephritis: IL-12p40 is the key Th1-defining cytokine chain, whereas IL-18 promotes local inflammation and leukocyte recruitment.

Authors:  A Richard Kitching; Amanda L Turner; Gabrielle R A Wilson; Timothy Semple; Dragana Odobasic; Jennifer R Timoshanko; Kim M O'Sullivan; Peter G Tipping; Kiyoshi Takeda; Shizuo Akira; Stephen R Holdsworth
Journal:  J Am Soc Nephrol       Date:  2005-05-11       Impact factor: 10.121

6.  BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells.

Authors:  Stephen E Gould; Maria Day; Simon S Jones; Haimanti Dorai
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

7.  Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis.

Authors:  Stéphanie Cherqui; Caroline Sevin; Ghislaine Hamard; Vasiliki Kalatzis; Mireille Sich; Marie O Pequignot; Karïn Gogat; Marc Abitbol; Michel Broyer; Marie-Claire Gubler; Corinne Antignac
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

8.  Gout-associated uric acid crystals activate the NALP3 inflammasome.

Authors:  Fabio Martinon; Virginie Pétrilli; Annick Mayor; Aubry Tardivel; Jürg Tschopp
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

9.  Improved renal function in children with cystinosis treated with cysteamine.

Authors:  T C Markello; I M Bernardini; W A Gahl
Journal:  N Engl J Med       Date:  1993-04-22       Impact factor: 91.245

10.  Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica.

Authors:  Catherine Dostert; Virginie Pétrilli; Robin Van Bruggen; Chad Steele; Brooke T Mossman; Jürg Tschopp
Journal:  Science       Date:  2008-04-10       Impact factor: 47.728

View more
  33 in total

1.  Apoptotic β-cells induce macrophage reprogramming under diabetic conditions.

Authors:  Meliza G Ward; Ge Li; Mingming Hao
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

Review 2.  An update on the role of the inflammasomes in the pathogenesis of kidney diseases.

Authors:  Murthy N Darisipudi; Felix Knauf
Journal:  Pediatr Nephrol       Date:  2015-07-16       Impact factor: 3.714

3.  Cystine accumulation attenuates insulin release from the pancreatic β-cell due to elevated oxidative stress and decreased ATP levels.

Authors:  Bernadette McEvoy; Rodolfo Sumayao; Craig Slattery; Tara McMorrow; Philip Newsholme
Journal:  J Physiol       Date:  2015-11-18       Impact factor: 5.182

4.  The proximal tubule in cystinosis: fight or flight?

Authors:  Robert L Chevalier
Journal:  J Am Soc Nephrol       Date:  2014-02-13       Impact factor: 10.121

Review 5.  Inflammasomes in the urinary tract: a disease-based review.

Authors:  J Todd Purves; F Monty Hughes
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-11

6.  Chitotriosidase as a Novel Biomarker for Therapeutic Monitoring of Nephropathic Cystinosis.

Authors:  Koenraad R P Veys; Mohamed A Elmonem; Maria Van Dyck; Mirian C Janssen; Elisabeth A M Cornelissen; Katharina Hohenfellner; Giusi Prencipe; Lambertus P van den Heuvel; Elena Levtchenko
Journal:  J Am Soc Nephrol       Date:  2020-04-09       Impact factor: 10.121

7.  Cell-Based Phenotypic Drug Screening Identifies Luteolin as Candidate Therapeutic for Nephropathic Cystinosis.

Authors:  Ester De Leo; Mohamed A Elmonem; Sante Princiero Berlingerio; Marine Berquez; Beatrice Paola Festa; Roberto Raso; Francesco Bellomo; Tobias Starborg; Manoe Jacoba Janssen; Zeinab Abbaszadeh; Sara Cairoli; Bianca Maria Goffredo; Rosalinde Masereeuw; Olivier Devuyst; Martin Lowe; Elena Levtchenko; Alessandro Luciani; Francesco Emma; Laura Rita Rega
Journal:  J Am Soc Nephrol       Date:  2020-06-05       Impact factor: 10.121

Review 8.  The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives.

Authors:  Stephanie Cherqui; Pierre J Courtoy
Journal:  Nat Rev Nephrol       Date:  2016-12-19       Impact factor: 28.314

Review 9.  The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction.

Authors:  Robert L Chevalier
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18

Review 10.  Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease.

Authors:  Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2016-08-11       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.